63PReal-life experience with the implementation of DLL3 staining and the subsequent treatment with rovalpituzumab tesirine in heavily pretreated SCLC patients

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 30; no. Supplement_2
Main Authors Hochmair, M J, Weinlinger, C, Fabikan, H, Koger, R, Krenbeck, D, Huemer, F, Illini, O M, Kulaksiz, M, Valipour, A, Burghuber, O C
Format Journal Article
LanguageEnglish
Published Oxford University Press 01.04.2019
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdz071.003